Who's Attending?
Accelerate the Clinical Translation of CAR-T, Treg & MSC-Based Therapies with Improved Efficacy, Durability & Safety to Revolutionize Curative Care for Chronic Autoimmune Disease
November 28-30, 2023 | Philadelphia, PA
Join the Inaugural Cell Therapy for Autoimmune Disease Summit!
Amidst the transformative impact of CAR-T and other cell therapies in cancer treatment, there is an electrifying sense of anticipation for their immense potential in indications beyond oncology. With compelling clinical results demonstrated in lupus, multiple sclerosis, pemphigus vulgaris, and many other autoimmune diseases, a wave of optimism surges forward. Moreover, the FDA’s rapid issuance of IND approvals and fast-track designations adds to the momentum of this groundbreaking approach, underscoring its potential to revolutionize the lives of millions affected by chronic autoimmune diseases worldwide.
Enter the inaugural Cell Therapy for Autoimmune Disease Summit, a pioneering platform singularly focused on uniting and empowering this community for the first time. Here, experts delve into cutting-edge frontiers of pre-clinical, translational, and clinical advancements encompassing all cell-based therapies, including CAR-T, Treg, and MSC, with the shared objective of developing better therapies for patients with chronic autoimmune diseases.
Why Attend?
Engage with your community and peers from leading pharma, biotech, and academia to build lasting connections and complementary collaborations
Build your understanding into the current challenges, strategies and solutions to fast-track development through the clinic
Discover how leading companies are harnessing the power of cell therapy to treat chronic autoimmune disease
The World-Class Speaker Faculty Includes:
Tamas Shisha
Executive Director, Head of Rheumatology Translational Medicine
Novartis Institutes for BioMedical Research
What Our Speakers Have to Say:
